ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 28 filers reported holding ADIAL PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $93,000 | +232.1% | 265,062 | +1156.2% | 0.00% | – |
| Q2 2022 | $28,000 | -73.3% | 21,100 | -45.8% | 0.00% | – |
| Q4 2021 | $105,000 | +101.9% | 38,900 | +92.6% | 0.00% | – |
| Q2 2021 | $52,000 | -71.1% | 20,198 | -72.8% | 0.00% | – |
| Q1 2021 | $180,000 | +37.4% | 74,291 | -3.5% | 0.00% | – |
| Q4 2020 | $131,000 | +44.0% | 76,971 | +190.5% | 0.00% | – |
| Q1 2019 | $91,000 | – | 26,492 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VANGUARD GROUP INC | 282,909 | $424,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 4,223 | $6,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 1,470 | $2,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 526 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 750 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 77,985 | $116,000 | 0.00% |
| MORGAN STANLEY | 535 | $1,000 | 0.00% |
| BROWN ADVISORY INC | 26,040 | $39,000 | 0.00% |
| BlackRock Inc. | 205,684 | $311,000 | 0.00% |